Protect Pharmaceutical Corp. (PRTT)
0.0652
-0.07
(-53.43%)
USD |
OTCM |
Oct 07, 16:00
Protect Pharmaceutical Enterprise Value : 3.751M for Oct. 7, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 07, 2026 | 3.751M |
| October 06, 2026 | 8.049M |
| October 05, 2026 | 7.817M |
| October 02, 2026 | 9.772M |
| October 01, 2026 | 9.772M |
| September 30, 2026 | 9.772M |
| September 29, 2026 | 9.772M |
| September 28, 2026 | 9.766M |
| September 25, 2026 | 8.623M |
| September 24, 2026 | 9.542M |
| September 23, 2026 | 8.192M |
| September 22, 2026 | 8.192M |
| September 21, 2026 | 11.50M |
| September 18, 2026 | 9.554M |
| September 17, 2026 | 11.10M |
| September 16, 2026 | 12.64M |
| September 15, 2026 | 14.37M |
| September 14, 2026 | 14.37M |
| September 11, 2026 | 11.48M |
| September 10, 2026 | 8.623M |
| September 09, 2026 | 8.623M |
| September 08, 2026 | 8.623M |
| September 04, 2026 | 10.35M |
| September 03, 2026 | 10.35M |
| September 02, 2026 | 10.35M |
| Date | Value |
|---|---|
| September 01, 2026 | 10.35M |
| August 31, 2026 | 10.35M |
| August 28, 2026 | 10.35M |
| August 27, 2026 | 11.46M |
| August 26, 2026 | 13.79M |
| August 25, 2026 | 14.37M |
| August 24, 2026 | 14.37M |
| August 21, 2026 | 14.37M |
| August 20, 2026 | 14.37M |
| August 19, 2026 | 19.14M |
| August 18, 2026 | 19.14M |
| August 17, 2026 | 20.11M |
| August 14, 2026 | 17.24M |
| August 13, 2026 | 15.80M |
| August 12, 2026 | 20.89M |
| August 11, 2026 | 20.89M |
| August 10, 2026 | 20.60M |
| August 07, 2026 | 20.11M |
| August 06, 2026 | 17.24M |
| August 05, 2026 | 17.24M |
| August 04, 2026 | 20.11M |
| August 03, 2026 | 19.17M |
| July 31, 2026 | 25.86M |
| July 30, 2026 | 25.86M |
| July 29, 2026 | 25.86M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| IGC Pharma, Inc. | 29.40M |
| Cryoport, Inc. | 760.35M |
| Cocrystal Pharma, Inc. | 13.71M |
| CNBX Pharmaceuticals, Inc. | 1.394M |
| Arvinas, Inc. | -73.22M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.02M |
| Total Expenses (Quarterly) | 0.02M |
| EPS Diluted (Quarterly) | -0.0004 |
| Earnings Yield | 176.4% |
| Normalized Earnings Yield | 176.38 |